Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Intiland Development Tbk. (DILD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Intiland Development Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Intiland Development Tbk. trades at Rp114 (market cap 1.2T, 13.47M 24h volume). The key difference: Intiland Development Tbk. is far larger — about 3.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Intiland Development Tbk. is more actively traded (13.47M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | DILD | |
|---|---|---|
Market Cap | 316.25B | 1.2T |
Volume | 41.7K | 13.47M |
Lot | 417 | 134.73K |
Turnover | 9.66M | 1.54B |
Average Price | 231.65 | 114.29 |
Value | 9.66M | 1.54B |
Indicative Equilibrium Price | 230 | 114 |
Indicative Equilibrium Volume | 2.4K | 146 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Intiland Development Tbk.
PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.
Read more on DILD →
